As of 2025-12-19, the Relative Valuation of Cardiol Therapeutics Inc (CRDL.TO) is (3.78) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.40 CAD, the upside of Cardiol Therapeutics Inc based on Relative Valuation is -369.7%.
The range of the Relative Valuation is (3.02) - (4.26) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 12.2x | 10.8x |
| Forward P/E multiples | 8.6x - 12.4x | 10.8x |
| Fair Price | (3.02) - (4.26) | (3.78) |
| Upside | -315.8% - -404.2% | -369.7% |
| Date | P/E |
| 2025-12-18 | -4.03 |
| 2025-12-17 | -4.00 |
| 2025-12-16 | -4.06 |
| 2025-12-15 | -4.00 |
| 2025-12-12 | -4.20 |
| 2025-12-11 | -4.29 |
| 2025-12-10 | -4.23 |
| 2025-12-09 | -4.29 |
| 2025-12-08 | -3.98 |
| 2025-12-05 | -4.09 |
| 2025-12-04 | -3.80 |
| 2025-12-03 | -3.80 |
| 2025-12-02 | -3.72 |
| 2025-12-01 | -3.69 |
| 2025-11-28 | -4.32 |
| 2025-11-27 | -4.20 |
| 2025-11-26 | -4.12 |
| 2025-11-25 | -4.23 |
| 2025-11-24 | -4.18 |
| 2025-11-21 | -3.95 |
| 2025-11-20 | -3.92 |
| 2025-11-19 | -4.03 |
| 2025-11-18 | -4.06 |
| 2025-11-17 | -3.98 |
| 2025-11-14 | -4.12 |
| 2025-11-13 | -4.20 |
| 2025-11-12 | -4.18 |
| 2025-11-11 | -4.12 |
| 2025-11-10 | -4.15 |
| 2025-11-07 | -4.00 |
| 2025-11-06 | -4.12 |
| 2025-11-05 | -4.38 |
| 2025-11-04 | -4.23 |
| 2025-11-03 | -4.40 |
| 2025-10-31 | -4.40 |
| 2025-10-30 | -4.38 |
| 2025-10-29 | -4.52 |
| 2025-10-28 | -4.60 |
| 2025-10-27 | -4.86 |
| 2025-10-24 | -4.75 |
| 2025-10-23 | -4.63 |
| 2025-10-22 | -4.78 |
| 2025-10-21 | -4.92 |
| 2025-10-20 | -4.29 |
| 2025-10-17 | -4.15 |
| 2025-10-16 | -4.18 |
| 2025-10-15 | -4.38 |
| 2025-10-14 | -4.18 |
| 2025-10-10 | -4.18 |
| 2025-10-09 | -4.40 |